Single nucleotide polymorphism discovery in TBX1 in individuals with and without 22q11.2 deletion syndrome
β Scribed by Carrie L. Heike; Jacqueline R. Starr; Mark J. Rieder; Michael L. Cunningham; Karen L. Edwards; Ian B. Stanaway; Dana C. Crawford
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 335 KB
- Volume
- 88
- Category
- Article
- ISSN
- 1542-0752
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
BACKGROUND:
Children with 22q11.2 deletion syndrome (22q11.2DS) have a wide range of clinical features. TBX1 has been proposed as a candidate gene for some of the features in this condition. Polymorphisms in the nondeleted TBX1, which may affect the function of the sole TBX1 gene in individuals with the 22q11.2DS, may be a key to understanding the phenotypic variability among individuals with a shared deletion. Comprehensive single nucleotide polymorphism (SNP) discovery by resequencing candidate genes can identify genetic variants that influence a given phenotype. The purpose of this study was to further characterize the sequence variability in TBX1 by identifying all common SNPs in this gene.
METHODS:
We resequenced TBX1 in 29 children with a documented 22q11.2 deletion and 95 nondeleted, healthy individuals. We estimated allele frequencies, performed tagSNP selection, and inferred haplotypes. We also compared SNP frequencies between 22q11.2DS and control samples.
RESULTS:
We identified 355 biallelic markers among the 190 chromosomes resequenced in the control panel. The vast majority of the markers identified were SNPs (n = 331), and the remainder indels (n = 24). We did not identify SNPs or indels in the cisβ regulatory element (FOXβbinding site) upstream of TBX1. In children with 22q11.2DS we detected 187 biallelic markers, six of which were indels. Four of the seven coding SNPs identified in the controls were identified in children with 22q11.2DS.
CONCLUSIONS:
This comprehensive SNP discovery data can be used to select SNPs to genotype for future association studies assessing the role of TBX1 and phenotypic variability in individuals with 22q11.2DS. Birth Defects Research (Part A) 2010. Β© 2009 WileyβLiss, Inc.
π SIMILAR VOLUMES
Malignant rhabdoid tumors are rare and aggressive neoplasms of childhood, occurring in the kidney or in various extrarenal locations. Most cytogenetic studies of these tumors have shown the frequent involvement of chromosome 22, including translocations and/or deletions, with a critical region for a